Assessment of Microglial Activation in Alzheimer Disease Using 18 F-PBR06 PET

Clin Nucl Med. 2023 Jul 1;48(7):643-644. doi: 10.1097/RLU.0000000000004630. Epub 2023 Mar 26.

Abstract

A 69-year-old woman with progressive short-term memory deficits was diagnosed with Alzheimer disease (MMSE 26/30, CDR 0.5) and underwent PET using 18 F-PBR06, a second-generation 18-kDa translocator protein ligand, targeting brain microglia and astrocytes. SUV and voxel-by-voxel binding potential maps (using simplified reference tissue method and a cerebellar pseudo-reference region) were generated. Images showed evidence of increased glial activation in biparietal cortices (including bilateral precuneus and posterior cingulate gyri) and bilateral frontal cortices. After 6 years of clinical follow-up, patient progressed to moderate cognitive impairment (CDR 2.0) and required assistance for activities of daily living.

Publication types

  • Case Reports

MeSH terms

  • Activities of Daily Living
  • Aged
  • Alzheimer Disease* / diagnostic imaging
  • Alzheimer Disease* / metabolism
  • Brain / diagnostic imaging
  • Brain / metabolism
  • Female
  • Humans
  • Microglia
  • Positron-Emission Tomography / methods